13F Pro

SEC Form 4 reporting owner

Dambkowski Carl

Dambkowski Carl has filed 47 Form 4 transactions reported between December 4, 2025 and September 3, 2026, as Chief Medical Officer of Apogee Therapeutics, Inc. and Director of Oruka Therapeutics, Inc..

Name as filed: Dambkowski Carl

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$18.0M
27 lines
Companies
2
with Form 4 filings
Latest transaction
Sep 3, 2026
transaction date

Roles and reported holdings

  • APGEApogee Therapeutics, Inc.
    Dec 4, 2025 – Sep 3, 2026

    Chief Medical Officer

    Held directly168,498 sh as of Aug 5, 2026 · Form 4

    24 months: $9.4M sold

  • ORKAOruka Therapeutics, Inc.
    Jan 23, 2026 – Jun 12, 2026

    Director

    Held directly38,743 sh as of Jun 12, 2026 · Form 4

    24 months: $8.6M sold

Transaction history

All 47 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 3, 2026APGEChief Medical OfficerDisposition to issuerCode D · direct83,690—Form 4
Sep 3, 2026APGEChief Medical OfficerDisposition to issuerCode D · direct124,962—Form 4
Sep 3, 2026APGEChief Medical OfficerDisposition to issuerCode D · direct110,665—Form 4
Sep 3, 2026APGEChief Medical OfficerDisposition to issuerCode D · direct167,123—Form 4
Sep 2, 2026APGEChief Medical OfficerDisposition to issuerCode D · direct1,375$186K@ $135.06Form 4
Aug 5, 2026APGEChief Medical OfficerOpen-market saleCode S · direct5,500$738K@ $134.17Form 4
Aug 5, 2026APGEChief Medical OfficerOption exerciseCode M · direct4,125$94K@ $22.86Form 4
Jul 14, 2026APGEChief Medical OfficerGiftCode G · direct8,000—Form 4
Jul 1, 2026APGEChief Medical OfficerOpen-market saleCode S · direct5,500$730K@ $132.74Form 4
Jul 1, 2026APGEChief Medical OfficerOption exerciseCode M · direct4,125$94K@ $22.86Form 4
Jun 22, 2026APGEChief Medical OfficerOpen-market saleCode S · direct26,400$3.5M@ $132.60Form 4
Jun 12, 2026ORKADirectorOpen-market saleCode S · direct12,583$882K@ $70.11Form 4
Jun 11, 2026ORKADirectorOpen-market saleCode S · direct22,417$1.6M@ $70.13Form 4
Jun 3, 2026APGEChief Medical OfficerOpen-market saleCode S · direct5,500$433K@ $78.71Form 4
Jun 3, 2026APGEChief Medical OfficerOption exerciseCode M · direct4,125$94K@ $22.86Form 4
Jun 2, 2026ORKADirectorGrant or awardCode A · direct9,136—Form 4
May 21, 2026ORKADirectorOpen-market saleCode S · direct13,235$794K@ $59.97Form 4
May 21, 2026ORKADirectorOpen-market saleCode S · direct53,447$3.2M@ $59.10Form 4
May 21, 2026ORKADirectorOpen-market saleCode S · direct38,318$2.2M@ $58.43Form 4
May 21, 2026ORKADirectorOption exerciseCode M · direct11,667$137K@ $11.77Form 4
May 21, 2026ORKADirectorOption exerciseCode M · direct11,904$93K@ $7.80Form 4
May 21, 2026ORKADirectorOption exerciseCode M · direct38,689$265K@ $6.84Form 4
May 6, 2026APGEChief Medical OfficerOpen-market saleCode S · direct1,800$152K@ $84.60Form 4
May 6, 2026APGEChief Medical OfficerOpen-market saleCode S · direct3,700$311K@ $83.92Form 4
May 6, 2026APGEChief Medical OfficerOption exerciseCode M · direct4,125$94K@ $22.86Form 4
Apr 1, 2026APGEChief Medical OfficerOpen-market saleCode S · direct100$9K@ $85.89Form 4
Apr 1, 2026APGEChief Medical OfficerOpen-market saleCode S · direct2,702$231K@ $85.33Form 4
Apr 1, 2026APGEChief Medical OfficerOpen-market saleCode S · direct2,698$227K@ $84.31Form 4
Apr 1, 2026APGEChief Medical OfficerOption exerciseCode M · direct4,125$94K@ $22.86Form 4
Mar 4, 2026APGEChief Medical OfficerOpen-market saleCode S · direct200$15K@ $73.26Form 4
Mar 4, 2026APGEChief Medical OfficerOpen-market saleCode S · direct2,075$149K@ $71.98Form 4
Mar 4, 2026APGEChief Medical OfficerOpen-market saleCode S · direct3,225$227K@ $70.33Form 4
Mar 4, 2026APGEChief Medical OfficerOption exerciseCode M · direct4,125$94K@ $22.86Form 4
Feb 4, 2026APGEChief Medical OfficerOpen-market saleCode S · direct200$14K@ $68.94Form 4
Feb 4, 2026APGEChief Medical OfficerOpen-market saleCode S · direct100$7K@ $67.88Form 4
Feb 4, 2026APGEChief Medical OfficerOpen-market saleCode S · direct1,299$87K@ $66.85Form 4
Feb 4, 2026APGEChief Medical OfficerOpen-market saleCode S · direct1,420$93K@ $65.83Form 4
Feb 4, 2026APGEChief Medical OfficerOpen-market saleCode S · direct2,481$161K@ $64.88Form 4
Feb 4, 2026APGEChief Medical OfficerOption exerciseCode M · direct4,125$94K@ $22.86Form 4
Jan 23, 2026ORKADirectorOther acquisition or dispositionCode J · direct116,483—Form 4
Jan 7, 2026APGEChief Medical OfficerOpen-market saleCode S · direct100$8K@ $80.06Form 4
Jan 7, 2026APGEChief Medical OfficerOpen-market saleCode S · direct826$65K@ $79.04Form 4
Jan 7, 2026APGEChief Medical OfficerOpen-market saleCode S · direct14,820$1.2M@ $77.90Form 4
Jan 7, 2026APGEChief Medical OfficerOpen-market saleCode S · direct2,954$228K@ $77.13Form 4
Jan 7, 2026APGEChief Medical OfficerOption exerciseCode M · direct14,025$321K@ $22.86Form 4
Jan 2, 2026APGEChief Medical OfficerGrant or awardCode A · direct83,690—Form 4
Dec 4, 2025APGEChief Medical OfficerOpen-market saleCode S · direct10,900$818K@ $75.00Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.